Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
MedTech
23andMine: Anne Wojcicki aims to take genetics company private
23andMe’s co-founder and CEO Anne Wojcicki plans to take the company private after its stock has collapsed by more than 97% since its market debut.
Conor Hale
Apr 18, 2024 9:16am
J&J CEO says M&A strategy to 'continue' after medtech megadeals
Apr 16, 2024 1:42pm
Illumina gets go-ahead from EU to part ways with Grail
Apr 12, 2024 10:11am
Novartis only wanted pelabresib, but MorphoSys had other ideas
Apr 12, 2024 8:53am
Steris carves out dentistry equipment business for $787M
Apr 11, 2024 1:38pm
Double autoimmune acquisitions as Century, Eliem pick up peers
Apr 11, 2024 9:06am